Disruption of traditional healthcare is inevitable and poses a central challenge for healthcare governance. While the size and complexity of the healthcare industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for healthcare governance.
Disruption of traditional healthcare is inevitable and poses a central challenge for healthcare governance. While the size and complexity of the healthcare industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for healthcare governance.
Disruption of traditional healthcare is inevitable and poses a central challenge for healthcare governance. While the size and complexity of the healthcare industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for healthcare governance.
Disruption of traditional healthcare is inevitable and poses a central challenge for healthcare governance. While the size and complexity of the healthcare industry have slowed the process of business disruption, its high costs and lack of convenience make it highly vulnerable to innovative, nontraditional competitors.
To make sure boards are well-prepared to address this challenge, McDermott Will & Emery and Kaufman Hall have partnered on a new thought leadership series designed to help you identify the signs of disruption, learn how to prepare your organization, and understand the implications for healthcare governance.
Michael Peregrine represents corporations in all areas of corporate governance law, and is recognized as one of the leading national practitioners and thought leaders in corporate governance. Read more.
Ken Kaufman is Chair of Kaufman Hall. He provides healthcare organizations with counsel and guidance in areas including strategy, finance, financial and capital planning, mergers and acquisitions, and partnerships. Read more.
Healthcare organizations seeking to respond to disruption, digital innovation and evolution in delivery models are consolidating at a rapid pace. These initiatives often involve significant risks, major mission shifts and challengingly short windows of opportunity—and the board’s traditional approach to decision-making increasingly falls short. Can the health system board move fast enough to make radical decisions that respond to business disruption, yet are still grounded in duty of care principles?
Business disruption is emerging as one of the most compelling corporate governance challenges for healthcare organizations. Through the development and oversight of a strategic governance and risk management plan, boards can make an extraordinary difference in responding to disruptive threats from innovative, non-traditional competitors.
As the forces of business disruption breach the healthcare sector, providers must adopt responsive strategies in order to guide their organizations through the challenge of meeting consumer demands for more convenient, affordable healthcare through significant technological investments, while balancing their fiduciary duty of managing costs.
Disruption in healthcare is a certainty. The four largest organizations in the world by market cap are closely watching this space and some are wading in. If you are part of the strategic planning or finance committees, you need to ensure that you understand and are planning for the threat that these and other players pose to the industry status quo.
Legal Notices | Privacy Policy
Attorney Advertising
